About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Feasibility of Florbetapir Quantitation

NCT01946243·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Avid Radiopharmaceuticals

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Readers have undergone Amyvid reader training
Readers have minimal experience with quantitation of amyloid PET scans

You may not be if

Readers have previously been trained to quantitate amyloid PET scans

The record

StatusCompleted

PhasePhase 4

Taking part96

StartedAug 2013

UpdatedJun 29, 2015

Conditions

Alzheimers Disease

Where1

Research Site
Philadelphia, Pennsylvania, United States

Clareo Health | The Feasibility of Florbetapir Quantitation